Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Validation of the World Health Organization Disability Assessment Schedule in people with severe mental disorders in rural Ethiopia.

Habtamu K, Alem A, Medhin G, Fekadu A, Dewey M, Prince M, Hanlon C.

Health Qual Life Outcomes. 2017 Apr 5;15(1):64. doi: 10.1186/s12955-017-0647-3.

2.

The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.

Velthorst E, Fett AJ, Reichenberg A, Perlman G, van Os J, Bromet EJ, Kotov R.

Am J Psychiatry. 2016 Dec 16:appiajp201615111419. [Epub ahead of print]

PMID:
27978770
3.

Development and validation of a contextual measure of functioning for people living with severe mental disorders in rural Africa.

Habtamu K, Alem A, Medhin G, Fekadu A, Prince M, Hanlon C.

BMC Psychiatry. 2016 Sep 7;16(1):311. doi: 10.1186/s12888-016-1022-3.

4.

Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.

Grove TB, Tso IF, Chun J, Mueller SA, Taylor SF, Ellingrod VL, McInnis MG, Deldin PJ.

Psychiatry Res. 2016 Sep 30;243:198-206. doi: 10.1016/j.psychres.2016.06.031. Epub 2016 Jun 25.

PMID:
27416540
5.

Counterfactual Reasoning Deficits in Schizophrenia Patients.

Contreras F, Albacete A, Castellví P, Caño A, Benejam B, Menchón JM.

PLoS One. 2016 Feb 1;11(2):e0148440. doi: 10.1371/journal.pone.0148440. eCollection 2016.

6.

Pain empathy in schizophrenia: an fMRI study.

Horan WP, Jimenez AM, Lee J, Wynn JK, Eisenberger NI, Green MF.

Soc Cogn Affect Neurosci. 2016 May;11(5):783-92. doi: 10.1093/scan/nsw002. Epub 2016 Jan 8.

7.

Effects of cognitive rehabilitation training on schizophrenia: 2 years of follow-up.

Tao J, Zeng Q, Liang J, Zhou A, Yin X, Xu A.

Int J Clin Exp Med. 2015 Sep 15;8(9):16089-94. eCollection 2015.

8.

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R.

Neuropsychiatr Dis Treat. 2015 Sep 10;11:2339-48. doi: 10.2147/NDT.S87335. eCollection 2015.

9.

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.

Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, Frese FJ, Goff DC, Gold JM, Hooker CI, Kopelowicz A, Loebel A, McGurk SR, Opler LA, Pinkham AE, Stern RG.

Schizophr Bull. 2016 Jan;42(1):19-33. doi: 10.1093/schbul/sbv111. Epub 2015 Sep 11.

10.

Construct Validity of the Chinese Version of the Activities of Daily Living Rating Scale III in Patients with Schizophrenia.

Chiu EC, Lee Y, Lai KY, Kuo CJ, Lee SC, Hsieh CL.

PLoS One. 2015 Jun 29;10(6):e0130702. doi: 10.1371/journal.pone.0130702. eCollection 2015.

11.

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia.

Cieslak K, Walsh-Messinger J, Stanford A, Vaez-Azizi L, Antonius D, Harkavy-Friedman J, Goetz D, Goetz RR, Malaspina D.

J Psychiatry Neurosci. 2015 Nov;40(6):387-93.

12.

Complexities of emotional responses to social and non-social affective stimuli in schizophrenia.

Peterman JS, Bekele E, Bian D, Sarkar N, Park S.

Front Psychol. 2015 Mar 25;6:320. doi: 10.3389/fpsyg.2015.00320. eCollection 2015.

13.

Validation of the German Version of the Social Functioning Scale (SFS) for schizophrenia.

Iffland JR, Lockhofen D, Gruppe H, Gallhofer B, Sammer G, Hanewald B.

PLoS One. 2015 Apr 2;10(4):e0121807. doi: 10.1371/journal.pone.0121807. eCollection 2015.

15.

Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.

Keefe RS, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, Patterson TD, Narasimhan M, Harvey PD.

Eur Neuropsychopharmacol. 2015 Feb;25(2):176-84. doi: 10.1016/j.euroneuro.2014.06.009. Epub 2014 Jun 28.

16.

Researchers' perspectives on the role of study partners in dementia research.

Black BS, Taylor H, Rabins PV, Karlawish J.

Int Psychogeriatr. 2014 Oct;26(10):1649-57. doi: 10.1017/S1041610214001203. Epub 2014 Jul 3.

17.

Variables associated with the use of coercive measures on psychiatric patients in Spanish penitentiary centers.

Girela E, López A, Ortega L, De-Juan J, Ruiz F, Bosch JI, Barrios LF, Luna JD, Torres-González F.

Biomed Res Int. 2014;2014:928740. doi: 10.1155/2014/928740. Epub 2014 Jan 20.

18.

Psychiatrists' perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa.

Gorwood P, Burns T, Juckel G, Rossi A, San L, Hargarter L, Schreiner A; Europe, Middle East and Africa functioning group.

Ann Gen Psychiatry. 2013 Mar 26;12(1):8. doi: 10.1186/1744-859X-12-8.

19.

A case-linkage study of crime victimisation in schizophrenia-spectrum disorders over a period of deinstitutionalisation.

Short TB, Thomas S, Luebbers S, Mullen P, Ogloff JR.

BMC Psychiatry. 2013 Feb 20;13:66. doi: 10.1186/1471-244X-13-66.

20.

Ecological Momentary Assessment of social functioning in schizophrenia: impact of performance appraisals and affect on social interactions.

Granholm E, Ben-Zeev D, Fulford D, Swendsen J.

Schizophr Res. 2013 Apr;145(1-3):120-4. doi: 10.1016/j.schres.2013.01.005. Epub 2013 Feb 10.

Supplemental Content

Support Center